Biodegradable cross-linked albumin microcapsules for embolization.
The interfacial polymerization process used in the present study produced individual cross-linked albumin microcapsules, the particle size of which depended on the emulsification stirring rate. The variation in cross-linking agent concentration altered the microcapsule wall properties. As shown by SEM observations, microcapsules prepared with low acyl chloride concentrations presented rippled surfaces, while the surfaces of the microcapsules prepared with high acyl chloride concentrations were smooth. It was then suggested that the membranes of the weakly cross-linked microcapsules consisted of cross-linked and denatured albumin. Embolization experiments in the dog kidney showed that the weakly cross-linked microcapsules were biodegradable within 7 days, whereas the highly cross-linked microcapsules were degraded over more than 14 days and led to prolonged ischaemia. The results of the histological experiments carried out on a further eight dogs supported the previous findings yielded by the angiographical experiments. Moreover, they indicated that no foreign body reaction occurred. The lack of this inflammatory granuloma should be attributed to the rapid biodegradation of the microcapsules which produced reversible ischaemic lesions.
D000818:Animals; D001673:Biodegradation, Environmental; D002214:Capsules; D003432:Cross-Linking Reagents; D004285:Dogs; D004339:Drug Compounding; D004621:Embolization, Therapeutic / Q000379:methods*; D007668:Kidney / Q000098:blood supply* / Q000000981:diagnostic imaging / Q000473:pathology; D010795:Phthalic Acids; D011859:Radiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D012709:Serum Albumin
D002214:Capsules; D003432:Cross-Linking Reagents; D010795:Phthalic Acids; D012709:Serum Albumin; C059743:terephthaloyl chloride